Health

Precede Biosciences Presents New Data at AACR LBx 2024 Demonstrating an Accurate Readout of Tumor PSMA Expression and Stratification of Response to Lutetium-PSMA in Men with mCRPC from a Simple Blood Test

Results show the potential of a real-time, non-invasive blood test to quantify tumor drug target expression and to stratify therapeutic…

6 days ago

Procaps Receives Nasdaq Listing Determination;To Request Hearing and Further Stay Pending Hearing

November 15, 2024 18:15 ET | Source: Procaps Group, S.A. MIAMI and BARRANQUILLA, Colombia, Nov. 15, 2024 (GLOBE NEWSWIRE) --…

6 days ago

Protara Therapeutics to Present New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the 25th Annual Meeting of the Society of Urologic Oncology

November 15, 2024 17:52 ET | Source: Protara Therapeutics NEW YORK, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq:…

6 days ago

Eagle Announces Update on Delisting from Nasdaq and SEC Deregistration

November 15, 2024 17:00 ET | Source: Eagle Pharmaceuticals, Inc. WOODCLIFF LAKE, N.J., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Eagle…

6 days ago

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

November 15, 2024 16:59 ET | Source: Annexon Biosciences BRISBANE, Calif., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq:…

6 days ago

Numab Therapeutics and Kaken Pharmaceutical Enter Collaborationand Option Agreement for Multi-specific Antibody ND081 for Treatment of Inflammatory Bowel Disease

Numab to receive R&D funding for the preclinical development of ND081 Kaken Pharmaceutical receives an option to in-license ND081 in…

7 days ago

AlveoGene Receives Rare Pediatric Disease Designation (RPDD)from FDA for AVG-002, its Novel, Inhaled Gene Therapy forLethal Neonatal Surfactant Protein B (SP-B) Deficiency

Inherited SP-B deficiency is an ultra-rare monogenic cause of fatal respiratory distress syndrome in newborn infantsClinical estimates for SP-B deficiency…

7 days ago

Aino Health AB (publ): interim report january-september 2024

This document in English is a translation of the original in Swedish. In case of any discrepancy, the Swedish original…

7 days ago

Bavarian Nordic Announces Interim Results for the First Nine Months of 2024

COPENHAGEN, Denmark, November 15, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today its interim financial results for the first…

7 days ago

NINER Pharmaceutical Strengthens Global Presence with Strategic IV Fluid Supply Initiative for the U.S. and Latin American Markets

DUBAI, United Arab Emirates, Nov. 15, 2024 (GLOBE NEWSWIRE) -- NINER Pharmaceutical, a leading name in the pharmaceutical sector, announces…

7 days ago